Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-26T18:06:43.589Z Has data issue: false hasContentIssue false
  • English
  • Français

Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms

Published online by Cambridge University Press:  02 November 2017

Kirstie L. McDermott ,
Nancy Fisher ,
Sandra Bradford  and
Richard Camicioli
Kirstie L. McDermott
Affiliation:
Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada
Nancy Fisher
Affiliation:
Department of Psychiatry, University of Alberta, Edmonton, Canada
Sandra Bradford
Affiliation:
Neuropsychology Clinic, University of Alberta, Edmonton, Canada
Richard Camicioli*
Affiliation:
Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada Department of Medicine (Neurology), University of Alberta, Edmonton, Canada
*
Correspondence should be addressed to: Richard Camicioli, Department of Medicine, Division of Neurology, 7 Clinical Sciences Building, University of Alberta, Edmonton, AB T6G 2E9Canada. Phone +780-248-1774. Email: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

We apply recently recommended Parkinson's disease mild cognitive impairment (PD-MCI) classification criteria from the movement disorders society (MDS) to PD patients and controls and compare diagnoses to that of short global cognitive scales at baseline and over time. We also examine baseline prevalence of neuropsychiatric symptoms across different definitions of MCI.

Methods:

51 PD patients and 50 controls were classified as cognitively normal, MCI, or demented using MDS criteria (1.5 or 2.0 SD below normative values), Clinical Dementia Rating Scale (CDR), and the Dementia Rating Scale (DRS). All subject had parallel assessment with the Neuropsychiatric inventory (NPI).

Results:

We confirmed that PD-MCI (a) is frequent, (b) increases the risk of PDD, and (c) affects multiple cognitive domains. We highlight the predictive variability of different criteria, suggesting the need for further refinement and standardization. When a common dementia outcome was used, the Level II MDS optimal testing battery with impairment defined as two SD below norms in 2+ tests performs the best. Neuropsychiatric symptoms were more common in PD across all baseline and longitudinal cognitive classifications.

Conclusions:

Our results advance previous findings on the utility of MDS PD-MCI criteria for PD patients and controls at baseline and over time. Additionally, we emphasize the possible utility of other cognitive scales and neuropsychiatric symptoms.

Keywords

Parkinson's diseasemild cognitive impairmentagingdementianeuropsychiatric symptoms
Type
Research Article
Information
International Psychogeriatrics , Volume 30 , Special Issue 2: Mild Behavioral Impairment , February 2018 , pp. 253 - 260
Copyright
Copyright © International Psychogeriatric Association 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., and Kragh-Sorensen, P. (2001). Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology, 56, 730–736. doi: https://doi.org/10.1212/WNL.56.6.730 CrossRefGoogle ScholarPubMed
Abdulaziz, K. et al. (2015). National survey of emergency physicians to define fucntional decline in elderly patients with minor trauma. Canadian Journal of Emergency Medicine, 17, 639–647. doi:10.1017/cem.2015.37 CrossRefGoogle Scholar
Broeders, M., de Bie, R. M., Velseboer, D. C., Speelman, J. D., Muslimovic, D. and Schmand, B. (2013). Evolution of mild cognitive impairment in Parkinson disease. Neurology, 81, 346–352. doi:10.1212/WNL.0b013e31829c5c86 CrossRefGoogle ScholarPubMed
Camicioli, R. et al. (2011). Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia. Movement Disorders, 26, 1443–50. doi: 10.1002/mds.23700 CrossRefGoogle ScholarPubMed
Cummings, J. L. (1994). The neuropsychiatric inventory: assessing psychopathy in dementia patients. Neurology, 48 (Suppl. 6), S10–S16.Google Scholar
Emre, M. et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders, 22, 1689–1707. doi:10.1002/mds.21507 CrossRefGoogle ScholarPubMed
Goldman, J. G., Holden, S., Ouyang, B., Bernard, B., Goetz, C. G. and Stebbins, G. T. (2015). Diagnosing PD-MCI by MDS task force criteria: how many and which neuropsychological tests?. Movement Disorders, 30, 402–406. doi:10.1002/mds.26084 Google Scholar
Goldman, J. G. and Litvan, I (2011). Mild cognitive impairment in Parkinson's disease. Minerva Medica, 102, 441–459.Google Scholar
Goldman, J. G., Weis, H., Stebbins, G., Bernard, B. and Goetz, C. G. (2012). Clinical differences among mild cognitive impairment subtypes in Parkinson's disease. Movement Disorders, 27, 1129–1136. doi:10.1002/mds.25062 CrossRefGoogle ScholarPubMed
Hobson, P. and Meara, J. (2015). Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. International Journal of Geriatric Psychiatry, 30, 1048–1055. doi:10.1002/gps.4261 CrossRefGoogle ScholarPubMed
Hoogland, J. et al. (2017). Mild cognitive impairment is a risk factor for Parkinson's disease dementia. Movement Disorders, 32, 1056–1065.Google Scholar
Ismail, Z. et al. (2016). Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioural impairment. Alzheimer's & Dementia, 12, 195–202. doi:10.1016/j.jalz.2015.05.017.Google Scholar
Ismail, Z. et al. (2017). The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations. Journal of Alzheimer's Disease, 56, 929–938. doi:10.3233/JAD-160979.Google Scholar
Janvin, C. C., Larsen, J. P., Aarsland, D. and Hugdahl, K. (2006). Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Movement Disorders, 21, 1343–1349. doi: 10.1002/mds.20974 Google Scholar
Leroi, I., Pantula, H., McDonald, K. and Harbishettar, V. (2012). Neuropsychiatric symptoms in Parkinson's disease with mild cognitive impairment and dementia. Parkinson's Disease, 2012, 1–10. doi:10.1155/2012/308097 Google Scholar
Liepelt-Scarfone, I. et al. (2011). Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson's disease. Parkinsons Disease, 2011. doi:10.4061/2011/540843 Google Scholar
Litvan, I. et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Movement Disorders, 27, 349–356. doi:10.1002/mds.24893 Google Scholar
Llebaria, G. et al. (2008). Cut-off score of the Mattis dementia rating scale for screening dementia in Parkinson's disease. Movement Disorders, 23, 1546–1550. doi: 10.1002/mds.22173 Google Scholar
Matteau, E., Dupre, N., Langlois, M., Provencher, P. and Simard, M. (2012). Clinical validity of the Mattis dementia rating scale-2 in Parkinson disease with MCI and dementia. Journal of Geriatric Psychiatry and Neurology, 25, 100–106. doi: 10.1177/0891988712445086 CrossRefGoogle ScholarPubMed
Monastero, R., Di Fiore, P., Ventimiglia, G. D., Camarda, R. and Camarda, C. (2013). The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment. Journal of Neural Transmission, 120, 607–611. doi:10.1007/s00702-013-0988-y CrossRefGoogle ScholarPubMed
Morris, J. C. (1993). The clinical dementia rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414. doi: https://doi.org/10.1212/WNL.43.11.2412-a CrossRefGoogle ScholarPubMed
Pedersen, K. F., Larsen, J. P., Tysnes, O. B. and Alves, G. (2013). Prognosis of mild cognitive impairment in early Parkinson disease: the norwegian park west study. JAMA Neurology, 70, 580–586. doi:10.1001/jamaneurol.2013.2110.Google Scholar
Petrovic, M., Stefanova, E., Ziropadja, L., Stojkovic, T. and Kostic, V. S. (2016). Neuro-psychiatric symptoms in Serbian patients with Parkinson's disease. Journal of the Neurological Sciences, 15, 342–346. doi: 10.1016/j.jns.2016.06.027 Google Scholar
Pirogovsky, E. et al. (2014). The utility of the mattis dementia rating scale in Parkinson's disease mild cognitive impairment. Parkinsonism & Related Disorders, 20, 627–631. doi:10.1016/j.parkreldis.2014.03.010 Google Scholar
Sabbagh, M. N. et al. (2005). Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?. Parkinsonism & Related Disorders, 11, 311–315. doi: https://doi.org/10.1016/j.parkreldis.2005.02.004 Google Scholar
Shulman, L. M. (2010). Understanding disability in Parkinson's disease. Movement Disorders, 25 (Suppl 1), S131–S135. doi:10.1002/mds.22789 Google Scholar
Strauss, E., Sherman, E. M. S. and Spreen, O. A. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford.Google Scholar
Villeneuve, S., Rodrigues-Brazete, J., Joncas, S., Postuma, R. B., Latreille, V. and Gagnon, J. F. (2011). Validity of the mattis dementia rating scale to detect mild cognitive impairment in Parkinson's disease and REM sleep behavior disorder. Dementia and Geriatric Cognitive Disorders, 31, 210–217. doi:10.1159/000326212 Google Scholar
Werheid, K., Hoppe, C., Thone, A., Muller, U., Mungersdorf, M. and von Cramon, D. Y. (2002). The adaptive Digit ordering test: clinical application, reliability, and validity of a verbal working memory test. Archives of Clinical Neurpsychology, 17, 547–565. doi: https://doi.org/10.1016/S0887-6177(01)00134-2 Google Scholar
Wood, K.-L. et al. (2016). Different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal study. Parkinson's Disease, 2, 15027. doi:10.1038/npjparkd.2015.27.Google Scholar
Wyman-Chick, K. A. and Scott, B. J. (2015). Development of clinical dementia rating scale cut-off scores for patients with Parkinson's disease. Movement Disorders Clinical Practice, 2, 243–248. doi:10.1002/mdc3.12163 CrossRefGoogle Scholar
Supplementary material: File

McDermott et al supplementary material

McDermott et al supplementary material 1

Download McDermott et al supplementary material(File)
File 37.2 KB